플라스미드 DNA는 세포/유전자 치료제의 원료 물질입니다. 빠르게 변경되는 규제 지침으로 플라스미드 DNA와 같은 원료 물질의 품질 정의를 변경하고 세포/유전자 치료제를 위한 GMP 원료의 조기 사용을 촉진하는 움직임이 커지고 있습니다.
웨비나를 통해 아래 내용에 대해 자세히 확인하세요.
Patrick Thiaville, PhD
Sr Staff Scientist, Research and Development
Patheon Pharma Services
Dr. Thiaville brings more than 20 years of experience in molecular biology and bacterial genetics to his role as Sr Staff Scientist of microbial manufacturing services for Patheon Pharma Services. He was awarded the prestigious Chateaubriand Fellowship from the French Embassy to United States where his graduate work focused on molecular genetics, genomics, and comparative genomics. Dr. Thiaville’s work in genetics lead to dual-doctorate degrees from the University of Florida and the University of Paris-Sud. Since joining Thermo Fisher Scientific, he has worked on design, scale up, and manufacturing of advanced therapeutics to serve patients in need. His passion remains focused on developing transformative new technologies to contribute to patient outcomes and make the world healthier.